drug
CYLTEZO
Marketedupdated 3mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7all catalysts(12)
approval · 12
Aug 25, 2017
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Sep 13, 2019
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Oct 15, 2021
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Mar 18, 2022
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Oct 3, 2022
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Mar 22, 2023
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
May 18, 2023
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Jun 30, 2023
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Jul 19, 2023
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Apr 30, 2024
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
May 20, 2025
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
Oct 16, 2025
approval
CYLTEZO (ADALIMUMAB-ADBM) — FDA approval
CYLTEZO
→
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that